Sildenafil Use in the Treatment of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Case Series

Amna Qasim, Soham Dasgupta, Ashraf Aly, Sunil Jain

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective This article studies the role of sildenafil in reducing myocardial stress (measured by serial N-terminal pro b-type natriuretic peptide [NTproBNP] levels) secondary to bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH). Study Design This is a case series of three extremely low birth weight infants with severe BPD at 36 weeks' postmenstrual age. All infants had very elevated NTproBNP (> 2,000 ng/dL) levels and echocardiographic evidence of BPD-PH. Sildenafil was started and infants were followed up every 2 weeks clinically along with NTproBNP levels and echocardiograms. Results After 4 weeks of sildenafil treatment, NTproBNP levels decreased significantly in all infants, echocardiograms showed significant improvement in one infant, and respiratory severity score improved significantly in one infant. All infants tolerated sildenafil. Conclusion Sildenafil reduced NTproBNP levels in all infants with BPD-PH but the echocardiographic findings and respiratory scores did not improve consistently. We speculate that this may be due to a delay in diagnosis and initiation of therapy after irreversible pulmonary changes have set in.

Original languageEnglish (US)
Pages (from-to)e219-e222
JournalAJP Reports
Volume8
Issue number4
DOIs
StatePublished - Jan 1 2018

Fingerprint

Bronchopulmonary Dysplasia
Pulmonary Hypertension
Natriuretic Peptides
Therapeutics
Extremely Low Birth Weight Infant
Sildenafil Citrate
Lung

Keywords

  • bronchopulmonary dysplasia
  • NTproBNP
  • pulmonary hypertension
  • pulmonary vasodilator

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Sildenafil Use in the Treatment of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension : A Case Series. / Qasim, Amna; Dasgupta, Soham; Aly, Ashraf; Jain, Sunil.

In: AJP Reports, Vol. 8, No. 4, 01.01.2018, p. e219-e222.

Research output: Contribution to journalArticle

@article{ea0962d892ef44c18645a4967e2ec440,
title = "Sildenafil Use in the Treatment of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Case Series",
abstract = "Objective This article studies the role of sildenafil in reducing myocardial stress (measured by serial N-terminal pro b-type natriuretic peptide [NTproBNP] levels) secondary to bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH). Study Design This is a case series of three extremely low birth weight infants with severe BPD at 36 weeks' postmenstrual age. All infants had very elevated NTproBNP (> 2,000 ng/dL) levels and echocardiographic evidence of BPD-PH. Sildenafil was started and infants were followed up every 2 weeks clinically along with NTproBNP levels and echocardiograms. Results After 4 weeks of sildenafil treatment, NTproBNP levels decreased significantly in all infants, echocardiograms showed significant improvement in one infant, and respiratory severity score improved significantly in one infant. All infants tolerated sildenafil. Conclusion Sildenafil reduced NTproBNP levels in all infants with BPD-PH but the echocardiographic findings and respiratory scores did not improve consistently. We speculate that this may be due to a delay in diagnosis and initiation of therapy after irreversible pulmonary changes have set in.",
keywords = "bronchopulmonary dysplasia, NTproBNP, pulmonary hypertension, pulmonary vasodilator",
author = "Amna Qasim and Soham Dasgupta and Ashraf Aly and Sunil Jain",
year = "2018",
month = "1",
day = "1",
doi = "10.1055/s-0038-1673343",
language = "English (US)",
volume = "8",
pages = "e219--e222",
journal = "AJP Reports",
issn = "2157-6998",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - Sildenafil Use in the Treatment of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

T2 - A Case Series

AU - Qasim, Amna

AU - Dasgupta, Soham

AU - Aly, Ashraf

AU - Jain, Sunil

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective This article studies the role of sildenafil in reducing myocardial stress (measured by serial N-terminal pro b-type natriuretic peptide [NTproBNP] levels) secondary to bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH). Study Design This is a case series of three extremely low birth weight infants with severe BPD at 36 weeks' postmenstrual age. All infants had very elevated NTproBNP (> 2,000 ng/dL) levels and echocardiographic evidence of BPD-PH. Sildenafil was started and infants were followed up every 2 weeks clinically along with NTproBNP levels and echocardiograms. Results After 4 weeks of sildenafil treatment, NTproBNP levels decreased significantly in all infants, echocardiograms showed significant improvement in one infant, and respiratory severity score improved significantly in one infant. All infants tolerated sildenafil. Conclusion Sildenafil reduced NTproBNP levels in all infants with BPD-PH but the echocardiographic findings and respiratory scores did not improve consistently. We speculate that this may be due to a delay in diagnosis and initiation of therapy after irreversible pulmonary changes have set in.

AB - Objective This article studies the role of sildenafil in reducing myocardial stress (measured by serial N-terminal pro b-type natriuretic peptide [NTproBNP] levels) secondary to bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH). Study Design This is a case series of three extremely low birth weight infants with severe BPD at 36 weeks' postmenstrual age. All infants had very elevated NTproBNP (> 2,000 ng/dL) levels and echocardiographic evidence of BPD-PH. Sildenafil was started and infants were followed up every 2 weeks clinically along with NTproBNP levels and echocardiograms. Results After 4 weeks of sildenafil treatment, NTproBNP levels decreased significantly in all infants, echocardiograms showed significant improvement in one infant, and respiratory severity score improved significantly in one infant. All infants tolerated sildenafil. Conclusion Sildenafil reduced NTproBNP levels in all infants with BPD-PH but the echocardiographic findings and respiratory scores did not improve consistently. We speculate that this may be due to a delay in diagnosis and initiation of therapy after irreversible pulmonary changes have set in.

KW - bronchopulmonary dysplasia

KW - NTproBNP

KW - pulmonary hypertension

KW - pulmonary vasodilator

UR - http://www.scopus.com/inward/record.url?scp=85055045890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055045890&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1673343

DO - 10.1055/s-0038-1673343

M3 - Article

AN - SCOPUS:85055045890

VL - 8

SP - e219-e222

JO - AJP Reports

JF - AJP Reports

SN - 2157-6998

IS - 4

ER -